{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:29:42Z","timestamp":1788715782400,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","award":["PID2022-141783OB-C22"],"award-info":[{"award-number":["PID2022-141783OB-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007064","name":"Universidad de Ja\u00e9n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101081327 YUFE4Postdocs"],"award-info":[{"award-number":["101081327 YUFE4Postdocs"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020069","name":"Industrial University of Santander Vice Chancellor&apos;s Office for Research and Extension","doi-asserted-by":"publisher","award":["3918"],"award-info":[{"award-number":["3918"]}],"id":[{"id":"10.13039\/501100020069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010781","name":"Centro de Instrumentaci\u00f3n Cient\u00edfico-T\u00e9cnica, Universidad de Ja\u00e9n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109306","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:48:14Z","timestamp":1764661694000},"page":"109306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quinolinyl-appended chalcones as promising antiproliferative and trypanocidal agents: Synthesis, biological profiling, and further transformation into novel benzo[f]pyrazolo[5,1-a][2,7]naphthyridine and quinoline-pyrido[2,3-d]pyrimidin-2,4-dione hybrids"],"prefix":"10.1016","volume":"168","author":[{"given":"Diego","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Moncada-Basualto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Rocha-Valderrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Stashenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alirio","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109306_bb0005","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetics in Cancer: fundamentals and beyond","volume":"173","author":"Biswas","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of Cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0020","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"10115","key":"10.1016\/j.bioorg.2025.109306_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109306_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107458","article-title":"Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020","volume":"260","author":"Lozano","year":"2024","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0035","article-title":"The cost of lost productivity due to premature Chagas disease-related mortality: lessons from Colombia (2010\u20132017)","volume":"6","author":"Olivera","year":"2021","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-018-9903-0","article-title":"The challenge of drug resistance in Cancer treatment: a current overview","volume":"35","author":"Nikolaou","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109306_bb0045","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1021\/acs.chemrev.0c00383","article-title":"Challenges and opportunities in Cancer drug resistance","volume":"121","author":"Ward","year":"2021","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109306_bb0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/bcp.14700","article-title":"Review of pharmacological options for the treatment of Chagas disease","volume":"88","author":"Lascano","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109306_bb0060","first-page":"9","article-title":"An overview on the therapeutics of neglected infectious diseases\u2014Leishmaniasis and Chagas diseases","author":"J","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0065","first-page":"14","article-title":"Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities","author":"Porta","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of Benznidazole by Trypanosomal type I Nitroreductases results in Glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/cpdd.871","article-title":"Biopharmaceutical characteristics of Nifurtimox tablets for age- and body weight-adjusted dosing in patients with Chagas disease","volume":"10","author":"Stass","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109306_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01135-20","article-title":"Adverse events associated with Nifurtimox treatment for Chagas disease in children and adults","volume":"65","author":"Berenstein","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2025.109306_bb0085","first-page":"56","article-title":"Tolerance and adherence of patients with chronic Chagas disease treated with Benznidazole","author":"V\u00e1zquez","year":"2023","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14787210.2021.1834849","article-title":"Benznidazole for the treatment of Chagas disease","volume":"19","author":"Losada Galv\u00e1n","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1017\/S0031182016000147","article-title":"Cancer and life-history traits: Lessons from host\u2013parasite interactions","volume":"143","author":"Ujvari","year":"2016","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109306_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/bies.201500163","article-title":"Host manipulation by Cancer cells: expectations, facts, and therapeutic implications","volume":"38","author":"Tissot","year":"2016","journal-title":"BioEssays"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0037-8682-0013-2014","article-title":"Cancer and parasitic infections: similarities and opportunities for the development of new control tools","volume":"47","author":"Oliveira","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"15","key":"10.1016\/j.bioorg.2025.109306_bb0110","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2217\/fon.14.65","article-title":"Mutual action of anticancer and Antiparasitic drugs: are there any shared targets?","volume":"10","author":"Dorosti","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.bioorg.2025.109306_bb0115","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.2147\/DDDT.S308973","article-title":"Progress in redirecting Antiparasitic drugs for Cancer treatment","volume":"15","author":"Huang","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109306_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3347\/kjp.2021.59.3.189","article-title":"Albendazole and Mebendazole as anti-parasitic and anti-Cancer agents: an update","volume":"59","author":"Chai","year":"2021","journal-title":"Korean J. Parasitol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0125","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s13346-021-01035-z","article-title":"Molecular hybridization combining tumor homing and penetrating peptide domains for cellular targeting","volume":"12","author":"Goyal","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0130","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.joule.2023.04.012","article-title":"Designing organic Pseudocapacitors through molecular hybridization","volume":"7","author":"Lakraychi","year":"2023","journal-title":"Joule"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/17460441.2024.2322990","article-title":"Molecular hybridization: a powerful tool for multitarget drug discovery","volume":"19","author":"de Sena Murteira Pinheiro","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109306_bb0140","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112904","article-title":"Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors","volume":"209","author":"Bass","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113072","article-title":"Synergistic effects of curcumin and its analogs with other bioactive compounds: a comprehensive review","volume":"210","author":"Hosseini-Zare","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109306_bb0155","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1016\/j.bmc.2012.03.011","article-title":"Antiplasmodial activity of novel keto-enamine Chalcone-chloroquine based hybrid pharmacophores","volume":"20","author":"Sashidhara","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0160","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone\u2013 and Chalcone\u2013Chloroquinoline hybrid analogues: in silico guided design, synthesis, Antiplasmodial activity, in vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109306_bb0165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00044-017-2076-6","article-title":"Synthesis and antiprotozoal activity of furanchalcone\u2013quinoline, furanchalcone\u2013chromone and furanchalcone\u2013imidazole hybrids","volume":"27","author":"Garc\u00eda","year":"2018","journal-title":"Med. Chem. Res."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109306_bb0170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF03402046","article-title":"Chalcone, acyl hydrazide, and related amides kill cultured Trypanosoma brucei (brucei)","volume":"6","author":"Troeberg","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.bioorg.2025.109306_bb0175","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ph17121705","article-title":"Antimicrobial activity of naphthyridine derivatives","volume":"17","author":"W\u00f3jcicka","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"14","key":"10.1016\/j.bioorg.2025.109306_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144324","article-title":"Biological activity of naturally derived Naphthyridines","volume":"26","author":"Chabowska","year":"2021","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.bioorg.2025.109306_bb0185","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.2174\/1385272825666210812102815","article-title":"Synthesis and biological activity of 2,7-Naphthyridine derivatives: an overview","volume":"25","author":"W\u00f3jcicka","year":"2021","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136451","article-title":"Synthesis of novel Pyrido[2,3-d]pyrimidine-Thiazolidine-1,2,3-Triazoles: potent EGFR targeting anticancer agents","volume":"1294","author":"Bandi","year":"2023","journal-title":"J. Mol. Struct."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109306_bb0195","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1002\/jhet.4109","article-title":"3D-pharmacophore study molecular docking and synthesis of Pyrido[2,3-d]Pyrimidine-4(1) Dione derivatives with in vitro potential anticancer and antioxidant activities","volume":"57","author":"Gouda","year":"2020","journal-title":"J. Heterocyclic Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0200","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1039\/D3RA00056G","article-title":"Medicinal chemistry perspective of Pyrido[2,3-d]pyrimidines as anticancer agents","volume":"13","author":"Kumar","year":"2023","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0205","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.tetlet.2014.01.128","article-title":"A convenient synthesis of novel 5-aryl-Pyrido[2,3-d]pyrimidines and screening of their preliminary antibacterial properties","volume":"55","author":"Saikia","year":"2014","journal-title":"Tetrahedron Lett."},{"issue":"01","key":"10.1016\/j.bioorg.2025.109306_bb0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4236\/ijoc.2022.121002","article-title":"One-pot synthesis of Pyrido[2,3-d]pyrimidines catalyzed by bismuth(III)Triflate","volume":"12","author":"Saglam","year":"2022","journal-title":"Int J Org Chem (Irvine)"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0215","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cbdd.13434","article-title":"One pot multi-component synthesis of functionalized Spiropyridine and Pyrido[2,3- d ]pyrimidine scaffolds and their potent in-vitro anti-inflammatory and anti-oxidant investigations","volume":"93","author":"Lavanya","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109306_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222010979","article-title":"Synthesis, in silico prediction and in vitro evaluation of antimicrobial activity, DFT calculation and theoretical investigation of novel Xanthines and uracil containing Imidazolone derivatives","volume":"22","author":"El-Kalyoubi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0225","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1021\/ml200004g","article-title":"Discovery of a highly potent and selective MEK inhibitor: GSK1120212 (JTP-74057 DMSO solvate)","volume":"2","author":"Abe","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0230","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/(SICI)1099-0690(200003)2000:5<849::AID-EJOC849>3.0.CO;2-R","article-title":"Synthesis of Ascididemine and an isomer","volume":"2000","author":"\u00c1lvarez","year":"2000","journal-title":"Eur. J. Org. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109306_bb0235","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1021\/jo00101a018","article-title":"Five new alkaloids from the tropical ascidian, Lissoclinum Sp. Lissoclinotoxin a is chiral","volume":"59","author":"Searle","year":"1994","journal-title":"J. Org. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2025.109306_bb0240","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1021\/jm00048a017","article-title":"Inhibition of topoisomerase II catalytic activity by Pyridoacridine alkaloids from a Cystodytes Sp. ascidian: a mechanism for the apparent Intercalator-induced inhibition of topoisomerase II","volume":"37","author":"McDonald","year":"1994","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0245","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1021\/acs.jnatprod.9b01107","article-title":"Isolation and synthesis of Veranamine, an antidepressant Lead from the marine sponge Verongula Rigida","volume":"83","author":"Kochanowska-Karamyan","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"88","key":"10.1016\/j.bioorg.2025.109306_bb0250","doi-asserted-by":"crossref","first-page":"55891","DOI":"10.1039\/C7RA12318C","article-title":"Use of unprotected amino acids in metal-free tandem radical cyclization reactions: divergent synthesis of 6-alkyl\/acyl Phenanthridines","volume":"7","author":"Lu","year":"2017","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0255","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/acs.orglett.9b01105","article-title":"Rhodium(I)-catalyzed aryl C\u2013H carboxylation of 2-arylanilines with CO2","volume":"21","author":"Gao","year":"2019","journal-title":"Org. Lett."},{"issue":"37","key":"10.1016\/j.bioorg.2025.109306_bb0260","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1039\/C7OB01285C","article-title":"Gold-catalyzed intramolecular cyclization\/condensation sequence: synthesis of 1,2-Dihydro[c][2,7]Naphthyridines","volume":"15","author":"Goutham","year":"2017","journal-title":"Org. Biomol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0265","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jhet.3938","article-title":"Multicomponent reactions and supramolecular catalyst: a perfect synergy for eco-compatible synthesis of Pyrido[2,3-d]pyrimidines in water","volume":"57","author":"Chate","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0270","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/423\/1\/012007","article-title":"Synthesis and biological activity of Pyrimido [1, 2- a ] Quinoline moiety and its 2-substituted derivatives","volume":"423","author":"Jadhav","year":"2013","journal-title":"J. Phys. Conf. Ser."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109306_bb0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1570193X17999200511010402","article-title":"Synthesis and biological evaluation of Pyrido[2,3-d]pyrimidines","volume":"18","author":"Yousif","year":"2021","journal-title":"Mini Rev Org Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109306_bb0280","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s10593-010-0507-0","article-title":"A convenient route for the synthesis of some new bi- and Triheterocondensed Uracils","volume":"46","author":"Abdel-Megid","year":"2010","journal-title":"Chem Heterocycl Compd (N Y)"},{"issue":"28","key":"10.1016\/j.bioorg.2025.109306_bb0285","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.tetlet.2011.05.021","article-title":"Improved synthesis of substituted Pyrido[2,3-d]Pyrimidinediones","volume":"52","author":"Churchill","year":"2011","journal-title":"Tetrahedron Lett."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109306_bb0290","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1002\/ejoc.201300683","article-title":"Efficient synthesis of uracil-derived Hexa- and Tetrahydropyrido[2,3- d ]pyrimidines","volume":"2013","author":"Tolstoluzhsky","year":"2013","journal-title":"Eur. J. Org. Chem."},{"issue":"30","key":"10.1016\/j.bioorg.2025.109306_bb0295","doi-asserted-by":"crossref","first-page":"23210","DOI":"10.1039\/C5RA00725A","article-title":"Cascade imination, buchwald\u2013hartwig cross coupling and cycloaddition reaction: Synthesis of pyrido[2,3-d]pyrimidines","volume":"5","author":"Saikia","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109306_bb0300","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ejmech.2017.08.017","article-title":"An integrative study to identify novel scaffolds for sphingosine kinase 1 inhibitors","volume":"139","author":"Vettorazzi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0305","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00044-018-2232-7","article-title":"Synthesis, anti-parasitic activity and QSAR study of a new library of polysubstituted tetrahydronaphtho[1,2-b]azepines","volume":"27","author":"Yepes","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.109306_bb0310","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1055\/s-0040-1706484","article-title":"Easy access to novel tetrahydro-1-benzazepine-2-carboxylic acids and tetrahydro-1-benzazepines carrying [a]-fused heterocyclic units from 2-(allylaryl)glycinates","volume":"53","author":"Guerrero","year":"2021","journal-title":"Synthesis"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109306_bb0315","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1055\/s-0039-1707985","article-title":"Straightforward synthesis of novel 4-Styrylquinolines\/4-Styrylquinolin-2-ones and 9-Styryldihydroacridin-1(2H)-ones from substituted 2\u2032-Aminochalcones","volume":"52","author":"Mel\u00e9ndez","year":"2020","journal-title":"Synthesis-Stuttgart"},{"issue":"29","key":"10.1016\/j.bioorg.2025.109306_bb0320","doi-asserted-by":"crossref","first-page":"20951","DOI":"10.1039\/D4RA03702B","volume":"14","author":"Rodr\u00edguez","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109306_bb0330","first-page":"s194","article-title":"Reaching a new highpoint with crystallography software-APEX3","volume":"A71","author":"Adam","year":"2015","journal-title":"Acta Crystallogr."},{"key":"10.1016\/j.bioorg.2025.109306_bb0335","series-title":"SAINT V8.40B","year":"2015"},{"key":"10.1016\/j.bioorg.2025.109306_bb0340","first-page":"3","article-title":"SHELXT-integrated space-group and crystal-structure determination","volume":"A71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr."},{"issue":"Pt 1","key":"10.1016\/j.bioorg.2025.109306_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Cryst. C Struct. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0350","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.109306_bb0355","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1107\/S1600576719014092","volume":"53","author":"Macrae","year":"2020","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.bioorg.2025.109306_bb0360","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","volume":"81","author":"Paull","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2025.109306_bb0365","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","volume":"83","author":"Monks","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bioorg.2025.109306_bb0370","first-page":"622","volume":"19","author":"Grever","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109306_bb0375","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1021\/jm00040a010","volume":"37","author":"Acton","year":"1994","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109306_bb0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109306_bb0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.275.5298.343","volume":"275","author":"Weinstein","year":"1997","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109306_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011107","article-title":"In vitro evaluation of new 5-Nitroindazolin-3-one derivatives as promising agents against Trypanosoma Cruzi","volume":"25","author":"Pozo-Mart\u00ednez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109306_bb0395","doi-asserted-by":"crossref","first-page":"o428","DOI":"10.1107\/S1600536813004765","article-title":"(2E)-1-(2,4-Dimethylquinolin-3-yl)-3-Phenylprop-2-en-1-one","volume":"69","author":"Prasath","year":"2013","journal-title":"Acta Cryst. Sect. E. Struct. Rep. Online"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109306_bb0400","doi-asserted-by":"crossref","first-page":"o1501","DOI":"10.1107\/S1600536812015498","article-title":"(E)-1-(2,4-Dimethylquinolin-3-il)-3-(4-Methylphenyl)prop-2-en-1-one","volume":"68","author":"Prasath","year":"2012","journal-title":"Acta Cryst. Sect. E. Struct. Rep. Online"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109306_bb0405","doi-asserted-by":"crossref","first-page":"o796","DOI":"10.1107\/S1600536811007835","article-title":"(2E)-3-(4-Chlorophenyl)-1-(2,4-Dimethylquinolin-3-Yl)Prop-2-En-1-one","volume":"67","author":"Prasath","year":"2011","journal-title":"Acta Cryst. Sect. E. Struct. Rep. Online"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109306_bb0410","doi-asserted-by":"crossref","first-page":"o2283","DOI":"10.1107\/S1600536811031485","article-title":"(2E)-1-(2,4-Dimethylquinolin-3-il)-3-(Thiophen-2-il)prop-2-en-1-one","volume":"67","author":"Prasath","year":"2011","journal-title":"Acta Cryst. Sect. E. Struct. Rep. Online"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0415","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1002\/slct.201602022","article-title":"New Quinoline linked Chalcone and Pyrazoline conjugates: molecular properties prediction, Antimicrobial and Antitubercular Activities","volume":"2","author":"Rao","year":"2017","journal-title":"ChemistrySelect"},{"issue":"35","key":"10.1016\/j.bioorg.2025.109306_bb0420","doi-asserted-by":"crossref","first-page":"21426","DOI":"10.1039\/D1RA03629G","article-title":"Development of Pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome Cancer invasion and metastasis","volume":"11","author":"Cao","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109306_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e133015","article-title":"Synthesis, characterization, preliminary molecular docking, pharmacological activity, and ADME studies of some new Pyrazoline derivatives as anti-breast Cancer agents","volume":"71","author":"Fadhil","year":"2024","journal-title":"Pharmacia"},{"key":"10.1016\/j.bioorg.2025.109306_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109075","article-title":"Design, synthesis and biological evaluation of novel Pyrazoline derivatives as dual EGFR\/VEGFR-2 inhibitors for targeted Cancer therapy","volume":"165","author":"Sawiris","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"52","key":"10.1016\/j.bioorg.2025.109306_bb0435","doi-asserted-by":"crossref","first-page":"31139","DOI":"10.1039\/D0RA05594H","article-title":"Molecular targets and anticancer activity of quinoline\u2013chalcone hybrids: Literature review","volume":"10","author":"Mohamed","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109306_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117203","article-title":"Synthesis strategies and anti-parasitic evaluation of novel compounds for Chagas disease: advancing drug discovery through structure-activity relationships","volume":"284","author":"Chaudhary","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.106980","article-title":"Intracellular ROS production and apoptotic effect of Quinoline and Isoquinoline alkaloids on the growth of Trypanosoma Evansi","volume":"245","author":"Rani","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2025.109306_bb0450","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.carbpol.2018.10.010","article-title":"Supramolecular hydrogels of \u03b2-Cyclodextrin linked to calcium Homopoly-l-Guluronate for release of Coumarins with Trypanocidal activity","volume":"204","author":"Moncada-Basualto","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109306_bb0455","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4155\/fmc-2018-0242","article-title":"Novel [1,2,3]Triazolo[1,5-a]pyridine derivatives are Trypanocidal by sterol biosynthesis pathway alteration","volume":"11","author":"Lapier","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109306_bb0460","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2020.12.009","article-title":"An exacerbated metabolism and mitochondrial reactive oxygen species contribute to mitochondrial alterations and apoptosis in CD4 T cells during the acute phase of Trypanosoma Cruzi infection","volume":"163","author":"Ana","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109306_bb0465","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0165-2478(99)00164-9","article-title":"N-acetylcysteine and glutathione modulate the behaviour of Trypanosoma Cruzi experimental infection","volume":"71","author":"Guevara","year":"2000","journal-title":"Immunol. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:27:15Z","timestamp":1773862035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":92,"alternative-id":["S0045206825011861"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109306","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinolinyl-appended chalcones as promising antiproliferative and trypanocidal agents: Synthesis, biological profiling, and further transformation into novel benzo[f]pyrazolo[5,1-a][2,7]naphthyridine and quinoline-pyrido[2,3-d]pyrimidin-2,4-dione hybrids","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109306"}}